Page 52 - Eve McCabe
P. 52
DIRECTION 2
WEARABLE ACTIVITY MONITORS
At Home Monitoring Devices
A) Evidence;
Monitors temperature, heart rate, sleep. Non-invasive.
Physical activity is important outcome for oncology trials.
Physical activity is commonly assessed using self-reported question-
naires, which are limited by response biases.
B) Criteria.
Sense of control over health. Keep their mind at ease being
able to keep an eye on numbers.
67·7% removed smart watch before clinical trials finished.
Reasons cited for removal included ‘discomfort and irritation’.
Self-Adhesive Biosensor
A) Evidence;
Automatically and continuously measures vital signs, body posture
and step count, and detects falls.
Using ‘wearable’ monitors to enable faster identification of physiologi-
cal deterioration for high risk patient groups.
B) Criteria.
Comfortable way to keep watch of patients in need of
frequent monitoring.
Can record symptoms, improvements and readings for
doctor. Adds a sense of ease knowing they are still
being monitored.
